SUBSCRIBE
SUBSCRIBE

Teva Pharmaceutical Industries Limited Announces Launch of Generic Prometrium® Capsules in the United States

March 2, 2012 | 
1 min read
JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today the commercial launch of Progesterone Capsules, 100 & 200 mg, the AB-rated generic equivalent of Abbott Laboratories’ Prometrium® Capsules.
Asia Europe
MORE ON THIS TOPIC
Podcast
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
April 30, 2025
 · 
1 min read
 · 
Heather McKenzie
Chess made from China and EU, USA flags. Europe Union, USA and China relations
Tariffs
China Still Go-To Source for New Drugs Despite Tariff Minefield
April 30, 2025
 · 
10 min read
 · 
Annalee Armstrong
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Cancer
Summit, Akeso’s Keytruda Challenger Wins Chinese OK as US Approval Questions Linger
April 28, 2025
 · 
3 min read
 · 
Tristan Manalac
Two boxing gloves give a fist bump on a colored background. Collage art
Lung cancer
Summit’s Bispecific Beats Yet Another Cancer Med, Pressuring Keytruda’s ‘Supremacy’
April 23, 2025
 · 
2 min read
 · 
Tristan Manalac